Listen to today’s podcast here!
A new study completed at the University of Alabama School of Medicine has found that calcium channel blockers are associated with lower levels of fasting serum glucose. Researchers examined data from about 5,000 adults who were part of the Reasons for Geographic & Racial Differences in Stroke study from 2003-2007.
This study found that adults who used calcium channel blockers had 5 mg/dL lower levels of serum glucose than nonusers. Users of the calcium channel blocker Verapamil had about 10 mg/dL lower serum glucose level than nonusers, with a significant difference among adults who used insulin.
These findings were published in Diabetes Research and Clinical Practice on January 15, 2016.